1. Home
  2. A vs DXCM Comparison

A vs DXCM Comparison

Compare A & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

N/A

Current Price

$160.27

Market Cap

38.0B

Sector

Industrials

ML Signal

N/A

Logo DexCom Inc.

DXCM

DexCom Inc.

N/A

Current Price

$92.36

Market Cap

33.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
A
DXCM
Founded
1999
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.0B
33.9B
IPO Year
1999
2005

Fundamental Metrics

Financial Performance
Metric
A
DXCM
Price
$160.27
$92.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
21
Target Price
$161.47
$85.33
AVG Volume (30 Days)
1.3M
5.4M
Earning Date
05-27-2026
04-30-2026
Dividend Yield
0.92%
N/A
EPS Growth
3.16
47.18
EPS
2.27
1.15
Revenue
$4,472,000,000.00
N/A
Revenue This Year
$8.45
$14.46
Revenue Next Year
$6.13
$12.31
P/E Ratio
$68.86
$78.46
Revenue Growth
6.43
N/A
52 Week Low
$108.35
$54.11
52 Week High
$160.27
$91.99

Technical Indicators

Market Signals
Indicator
A
DXCM
Relative Strength Index (RSI) 81.24 69.50
Support Level $135.76 $62.02
Resistance Level $160.27 N/A
Average True Range (ATR) 3.68 2.53
MACD 1.10 0.16
Stochastic Oscillator 98.83 98.86

Price Performance

Historical Comparison
A
DXCM

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Share on Social Networks: